Houston, TX, United States of America

Bill Nai-Chau Sun


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 1995-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bill Nai-Chau Sun: Innovator in HIV-1 Neutralization

Introduction

Bill Nai-Chau Sun is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of immunology, particularly in the development of innovative therapies for HIV-1 infection. With a total of 2 patents, his work has the potential to impact the treatment and prevention of AIDS and related conditions.

Latest Patents

One of his latest patents focuses on immunoconjugates that neutralize HIV-1 infection. This patent reveals monoclonal antibodies that bind to the gp120 protein on the envelope of HIV-1. These antibodies are capable of neutralizing HIV-1 and inhibiting the infection of T cells, as well as preventing syncytium formation. Notably, these antibodies are group-specific and can neutralize various strains and isolates of HIV-1. Their applications extend to the treatment and prevention of AIDS and ARC, and they are utilized in immunotoxins that specifically target HIV-1 infected T cells. Another significant patent involves anti-idiotype antibodies that are specific for the parotope of antibodies. These anti-idiotypic monoclonal antibodies recognize unique antigenic epitopes of IgE, which are present on membrane-bound IgE expressed by bearing B cells, but not on IgE bound to Fc.epsilon.R on basophils.

Career Highlights

Bill Nai-Chau Sun is associated with Tanox Biosystems, Inc., where he continues to advance his research and development efforts. His work has garnered attention in the scientific community for its innovative approach to combating HIV-1.

Collaborations

He collaborates with notable colleagues, including Tse-wen Chang and Cecily Rou-Yun Sun, who contribute to his research endeavors.

Conclusion

Bill Nai-Chau Sun's innovative work in the field of immunology, particularly regarding HIV-1 neutralization, showcases his dedication to advancing medical science. His patents reflect a commitment to developing effective therapies that could change the landscape of HIV treatment and prevention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…